Transaminase elevation during the first trimester and early pregnancy loss in patients with recurrent spontaneous abortion: a cross-sectional study

Abstract

Objective: To investigate the association between transaminase elevation during the first trimester and early pregnancy loss (EPL) in patients with recurrent spontaneous abortion (RSA). Further, the contributing risk factors for transaminase elevation in early pregnancy in RSA patients were analyzed Design: Cross-sectional study Setting: China Population: RSA patients during the first trimester Methods: Patients were divided into EPL group and N-EPL group as well as transaminase-elevated group (TE group) and transaminase-normal group (TN group). The relationship between transaminase level and EPL and the risk factors of elevated transaminase were investigated via student’s t test, Pearson chi-square test and logistic regression analyses. Main outcome measure: The association between transaminase elevation and EPL and the risk factors for elevated transaminase. Results: Higher serum transaminase levels were observed in EPL group than in the N-EPL group (p <0.05). Comparing with TN group, EPL is more common in TE group (p =0.018). There is still a correlation between elevated transaminases and EPL in RSA patients after adjusting for covariates (AST: OR, 1.018; 95% CI, 1.007-1.029; p, 0.001; ALT: OR, 1.006; 95%CI, 1.001-1.011; p, 0.018). The higher the transaminases, the greater the likelihood of EPL (p <0.05). Multivariate regression analysis found that the use of IVIG was an independent risk factor for elevated transaminase in RSA patients (OR, 0.374; 95% CI, 0.162-0.864; p =0.021). Conclusion: Serum transaminase levels are significantly correlated with RSA early pregnancy loss. Moreover, medication use is significantly correlated with transaminase elevation in the first trimester in RSA patients, especially IVIG.